X-PRES TCELL
LIVE

Serial Number

90640633

Owner

GI Cell, Inc.

Attorney

James R Menker

Filing Date

Apr 13, 2021

Add to watchlist:

No watchlists yet
View on USPTO

X-PRES TCELL Trademark

Serial Number: 90640633 • Registration: 6771240

X-PRES TCELL is a trademark filed by GI Cell, Inc. on April 13, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

GI Cell, Inc. (6 trademarks)

#1014, B-dong, 167
Seoul 05855 , KR

Entity Type: 03

Trademark Details

Filing Date

April 13, 2021

Registration Date

June 28, 2022

Published for Opposition

April 12, 2022

Goods & Services

Pharmaceutical preparations for the prevention of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral diseases; Vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Vitamin preparations; Cellular function activating agents for medical purposes; Pharmaceutical preparations for the treatment of cells; Medicines for intestinal disorders; Pharmaceutical products for the treatment of cancer; Anti-inflammatory preparations; Dietary food supplements; Cells for medical or clinical use; Biological preparations for the treatment of cancer; Dietary and nutritional supplements; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue

Sales agency services in the nature of retail services by direct solicitation by sales agents of health food supplements mainly based on grain extracts; sales arranging services in the nature of retail services by direct solicitation by sales agents of health food supplements mainly based on grain extracts; retail store services of health food supplements mainly based on grain extracts; sales arranging services in the nature of retail services by direct solicitation by sales agents of health food supplements mainly based on fruit extracts; retail store services of health food supplements mainly based on fruit extracts; sales agency services in the nature of retail services by direct solicitation by sales agents of health food supplements mainly based on fruit extracts; advertising services; wholesale store services featuring nonprescription medicines; retail store services featuring nonprescription medicines; sales agency services in the nature of retail services by direct solicitation by sales agents for nonprescription medicines; import and export agencies; retail store services of health food supplements consisting primarily of lactobacillus culture fluid; sales agency in the nature of retail services by direct solicitation by sales agents of health food supplements consisting primarily of lactobacillus culture fluid; sales arranging in the nature of retail services by direct solicitation by sales agents of health food supplements consisting primarily of lactobacillus culture fluid; retail store services of health food supplements mainly based on grain extracts consisting of lactic acid bacteria; sales agency in the nature of retail services by direct solicitation by sales agents of health food supplements mainly based on grain extracts consisting of lactic acid bacteria; sales arranging in the nature of retail services by direct solicitation by sales agents of health food supplements mainly based on grain extracts consisting of lactic acid bacteria; retail store services of health food supplements mainly based on vegetable extracts consisting of lactic acid bacteria; sales agency in the nature of retail services by direct solicitation by sales agents of health food supplements mainly based on vegetable extracts consisting of lactic acid bacteria; sales arranging in the nature of retail services by direct solicitation by sales agents of health food supplements mainly based on vegetable extracts consisting of lactic acid bacteria; wholesale store services featuring pharmaceuticals; advertising relating to pharmaceutical products and in-vivo imaging products; retail store services featuring pharmaceuticals; business intermediary services relating to the purchase and sale of pharmaceuticals, namely, procuring of contracts for the purchase and sale of goods; sales agency services in the nature of retail services by direct solicitation by sales agents for pharmaceuticals; sales arranging in the nature of retail services by direct solicitation by sales agents of pharmaceuticals; demonstration of goods relating to pharmaceutical products; business intermediary services relating to the purchase and sale of pharmaceuticals via an on-line communications network on the internet, namely, procuring of contracts for the purchase and sale of goods; wholesale store services featuring pharmaceuticals via an on-line communications network on the internet; retail store services featuring pharmaceuticals via an on-line communications network on the internet; sales agency services in the nature of retail services by direct solicitation by sales agents for pharmaceuticals via an on-line communications network on the internet; sales arranging in the nature of retail services by direct solicitation by sales agents of pharmaceuticals via an on-line communications network on the internet; retail store services of health food supplements mainly based on vegetable extracts; sales agency services in the nature of retail services by direct solicitation by sales agents in the nature of retail services by direct solicitation by sales agents of health food supplements mainly based on vegetable extracts; sales arranging services in the nature of retail services by direct solicitation by sales agents of health food supplements mainly based on vegetable extracts

Research and development of vaccines and medicines; biotechnological research; advisory services relating to biotechnology; development of cell therapy products; scientific research for medical purposes in the field of cancerous diseases; pharmaceutical products development; pharmaceutical research services; structural and functional analysis of genomes; scientific research in the field of genetics and genetic engineering; testing of pharmaceuticals; stem cell research; cell culture services for scientific and research purposes, for others; medical research; product safety testing services; quality control for others; cosmetic research

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 28, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 28, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 12, 2022 NPUB
PUBLISHED FOR OPPOSITION
Apr 12, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 23, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 4, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 7, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 6, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 9, 2021 GNRN
NON-FINAL ACTION E-MAILED
Dec 9, 2021 GNRT
NON-FINAL ACTION WRITTEN
Dec 9, 2021 CNRT
ASSIGNED TO EXAMINER
Dec 4, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 20, 2021 NWOS
NEW APPLICATION ENTERED
Apr 16, 2021 NWAP